SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
SEC Accession No. 0000950134-08-002526
Filing Date
2008-02-14
Accepted
2008-02-13 18:00:17
Documents
1
Group Members
ALEXANDER E BARKASDAVID SCHNELLJAMES B TANANBAUMPROSPECT MANAGEMENT CO III LLCRUSSELL C HIRSCH

Document Format Files

Seq Description Document Type Size
1 AMENDMENT TO SCHEDULE 13D f37890sc13dza.htm SC 13D/A 117819
  Complete submission text file 0000950134-08-002526.txt   119825
Mailing Address 60 WESTVIEW STREET LEXINGTON MA 02421
Business Address 60 WESTVIEW STREET LEXINGTON MA 02421 781-402-5700
CRITICAL THERAPEUTICS INC (Subject) CIK: 0001145404 (see all company filings)

IRS No.: 043523569 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-79887 | Film No.: 08606711
SIC: 2834 Pharmaceutical Preparations

Mailing Address 435 TASSO ST SUITE 200 PALO ALTO CA 94301
Business Address 435 TASSO ST SUITE 200 PALO ALTO CA 94301 650-327-8800
Prospect Venture Partners III L P (Filed by) CIK: 0001311490 (see all company filings)

IRS No.: 000000000
Type: SC 13D/A